MMP‐2 and MMP‐9 not only modulate inflammatory responses through pro‐inflammatory cytokine release in cholesteatoma microenvironments, but also have been characterized in histopathological specimens as a biomarker predictive of ossicular chain destruction [52]. Here, MMP9 is linked to cholesteatoma.